In this section we can find the latest news about medical treatments used in rare cancers.

Scientific research, with its recent progress, allowed to lay on the lab bench a wide range of new molecules, which today are the basis of so-called targeted molecular therapies.

Among these, some have already arrived at the bedside, having successfully passed the various stages of clinical trials, showing good tolerability and efficacy profiles, sometimes really surprising.

the following information, given in the typical FAQ format, are particularly suitable for the non experts.